| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T35 |
10-21 |
DG_35 |
denotes |
Tocilizumab |
| T10312 |
10-21 |
DG_35 |
denotes |
Tocilizumab |
| T36 |
75-86 |
CL:0000080 |
denotes |
circulating |
| T74668 |
75-86 |
CL:0000080 |
denotes |
circulating |
| T37 |
87-98 |
CL:0000542 |
denotes |
lymphocytes |
| T90672 |
87-98 |
CL:0000542 |
denotes |
lymphocytes |
| T38 |
128-134 |
UBERON:0002405 |
denotes |
immune |
| T2958 |
128-134 |
UBERON:0002405 |
denotes |
immune |
| T39 |
135-148 |
GO:0065007 |
denotes |
dysregulation |
| T86620 |
135-148 |
GO:0065007 |
denotes |
dysregulation |
| T40 |
159-167 |
SP_7 |
denotes |
COVID-19 |
| T3195 |
159-167 |
SP_7 |
denotes |
COVID-19 |
| T41 |
188-192 |
PR:000001393 |
denotes |
IL-6 |
| T88472 |
188-192 |
PR:000001393 |
denotes |
IL-6 |
| T42 |
206-209 |
PR:000029150 |
denotes |
HLA |
| T6458 |
206-209 |
PR:000029150 |
denotes |
HLA |
